American Cancer Society blesses virtual colonoscopy for screening
The American Cancer Society has added CT colonography to its approved list of colon cancer screening methods. Released this week, the new guidelines designate virtual colonoscopy as a “preferred” test that “finds polyps and cancer” and should be performed every five years.
The American Cancer Society has added CT colonography to its approved list of colon cancer screening methods. Released this week, the new guidelines designate virtual colonoscopy as a "preferred" test that "finds polyps and cancer" and should be performed every five years.
Other tests, such as fecal occult blood testing, are described as less likely to pinpoint polyps. This is the first time the ACS has favored one specific type of test over another, according to Dr. Durado Brooks, director of prostate and colorectal cancer for the ACS.
The new listing is the second boost that CTC has received in the last few months. In late 2007, outcomes from the ACRIN 6664 trial deemed CTC comparable to standard colonoscopy for screening intermediate and large-sized polyps. In the trial, the prevalence of lesions at 6 mm or larger came in at a low 8.3%. As a result, most patients who undergo CTC would not also require therapeutic colonoscopy, according to the ACRIN trial leaders.
Virtual colonoscopy's inclusion in the ACS guidelines should be a major boon in the reimbursement arena for the modality
For more information from the Diagnostic Imaging archives:
CTC pushes for rightful place in colorectal cancer screening
Philips' filet irons kinks out of virtual colonoscopy
European trial data bolster argument for CT colonography
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
